Blockchain Registration Transaction Record

CNS Pharmaceuticals to Present Abstract at 2024 SNO/ASCO CNS Cancer Conference

CNS Pharmaceuticals, a biopharmaceutical company, will present an abstract at the 2024 SNO/ASCO CNS Cancer Conference. The event highlights the development of potential treatments for aggressive brain cancer.

CNS Pharmaceuticals to Present Abstract at 2024 SNO/ASCO CNS Cancer Conference

This news matters as it highlights the participation of CNS Pharmaceuticals in a major cancer conference and the development of potential treatments for aggressive brain cancer, impacting patients and investors in the biopharmaceutical industry.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x68f87b43c7e1faec15ae48cba9f28a827ab70fa68a9de1e0189facd70aebb468
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintninaYrbb-c540e96c748549f7554199816cfef56b